Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Child Abuse Negl. 2019 Jul;93:119–127. doi: 10.1016/j.chiabu.2019.05.006

The relationship between childhood emotional abuse and chronic pain among people who inject drugs in Vancouver, Canada

Amy Prangnell a,b, Pauline Voon a,b, Hennady Shulha a, Ekaterina Nosova a, Jean Shoveller a,b, M-J Milloy a,c, Thomas Kerr a,c, Kanna Hayashi a,d
PMCID: PMC6658124  NIHMSID: NIHMS1531275  PMID: 31103834

Abstract

Background:

People who inject drugs (PWID) often contend with chronic pain as a result of illness and trauma, and such pain is known to have significant impacts on mental health, quality of life, and substance use behaviours. Although PWID are also known to have high rates of childhood trauma, little is known about how childhood emotional abuse may be associated with chronic pain in this population.

Objective:

We undertook this study to explore emotional abuse and chronic pain among PWID.

Participants and Setting:

This study comprised a total of 1,459 participants in Vancouver, Canada between June 2014 and November 2016.

Methods:

We employed multivariable generalized estimating equations with data derived from two prospective cohort studies of community-recruited PWID to examine the relationship between childhood emotional abuse and chronic pain in the past six months.

Results:

Among eligible participants, 591 (40.5%) reported childhood emotional abuse, and 760 (52.1%) reported chronic pain in the previous six months. In a multivariable analysis, experiencing childhood emotional abuse remained independently associated with chronic pain (adjusted odds ratio: 1.25; 95% confidence interval: 1.01–1.53) after adjustment for a range of socio-demographic and drug use confounders.

Conclusions:

Our findings suggest that childhood emotional abuse may have lasting relationships with chronic pain among PWID, potentially through established physiological and psychological mechanisms. Current chronic pain treatment may benefit from the evaluation of life course vulnerabilities that may be amenable to earlier interventions. Further, increased availability of effective trauma-informed chronic pain treatment is needed among this vulnerable population.

Keywords: Childhood emotional abuse, child trauma, chronic pain, morbidity

INTRODUCTION

Chronic pain, classified as significant pain lasting longer than three months and beyond normal healing time, occurs in approximately 20% of general, adult populations (Fayaz, Croft, Langford, Donaldson, & Jones, 2016; Treede et al., 2015; van Hecke, Torrance, & Smith, 2013). In comparison, higher proportions of people who use drugs (33% to 37%) report chronic pain (Heimer, Zhan, & Grau, 2015; Rosenblum et al., 2003). Other population subgroups also report increased risk of chronic pain including women, seniors, and those from low socio-economic status backgrounds (van Hecke et al., 2013). Medical conditions with chronic pain range from general widespread pain, migraines, headaches, low back pain, musculoskeletal pain, fibromyalgia, to joint pain (Jackson et al., 2016). The consequences of chronic pain are vast and include a reduced ability to maintain work, lower quality of life, increased mortality, increased risk of depression and anxiety, and hampered ability to participate fully in daily life (Andrew, Derry, Taylor, Straube, & Phillips, 2014; Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006; Lamé, Peters, Vlaeyen, Kleef, & Patijn, 2005). In addition, individuals with chronic pain report significantly higher health care utilization (e.g., physician visits; medication use) (Andrew et al., 2014).

To date prescription opioids remain the most common form of medical therapy for severe acute pain. However, there are increasing concerns with long-term use of prescription opioids: primarily questions regarding their effectiveness/benefits (particularly over long-term use), concerns relating to side effects, and recently, a recognition that prescription opioids can contribute to substance use disorders and overdose-related mortality (Chou et al., 2015; Ives et al., 2006; Rosenblum, Marsch, Joseph, & Portenoy, 2008). These concerns, alongside the implementation of clinical practice guidelines in some jurisdictions (Cheung et al., 2014), have contributed to uncertainty and reluctance in clinical practice to initiate or maintain opioid treatment regimens for patients presenting with chronic pain (Chang & Compton, 2013). As a result, people who inject drugs (PWID) are often forced to resort to self-medication for chronic pain, such as injecting illicitly acquired heroin or contraband prescription opioids (Alford et al., 2016; Voon et al., 2014). In light of the high proportion of chronic pain experienced by PWID, alongside the significant impacts of both pain and substance use disorders, clinicians and patients face complex challenges in terms of the provision of effective pain treatment options (Andrew, Derry, Taylor, Straube, & Phillips, 2014; Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006; Heimer, Zhan, & Grau, 2015; Rosenblum et al., 2003).

To further understand this complexity, it is important to recognize that previous studies have shown that various forms of childhood abuse (e.g., physical, sexual, emotional) are also associated with higher likelihood of chronic pain and injection drug use during adulthood (Eriksen et al., 2016; Kerr et al., 2009; Lampe et al., 2000; Walsh, Jamieson, MacMillan, & Boyle, 2007). While less is known regarding the impact of childhood emotional abuse, especially among PWID, there is now compelling evidence suggesting childhood emotional abuse may be the most significant predictor of negative health outcomes among the childhood maltreatment categories (Glaser, 2002; Kaplan, Pelcovitz, & Labruna, 1999; Rees, 2010). This may be largely due to increased risk of psychological distress, poor mental health outcomes, decreased ability to cope with stressful situations, and detrimental impact on family relationships (Dias, Sales, Hessen, & Kleber, 2015; Rees, 2010).

Childhood emotional abuse, or psychological abuse, has broadly been defined as a failure to provide developmentally appropriate and supportive environments for a child, which have reason to result in psychological harm to the child (Rees, 2010). This can take the form of insults, humiliation, isolation, excessive punishment, or manipulation among many others (Kairys & Johnson, 2002; Norman et al., 2012). While rates of childhood emotional abuse are difficult to ascertain due to the lack of physical evidence, it is likely the most prevalent category of childhood abuse because of its frequent co-occurrence with sexual and physical abuse, as well as occurring on its own (Kaplan et al., 1999). Rates of childhood emotional abuse differ among various groups with estimates ranging from 7% to 26% (Cammack & Hogue, 2017; Dube et al., 2001; Schilling et al., 2016). Among people who use drugs, rates of exposure to childhood emotional abuse are estimated to be much higher than among people who do not use drugs, with estimates ranging from 44% to 46% (Lake, Hayashi, et al., 2015; Taplin, Saddichha, Li, & Krausz, 2014).

Prior research has identified a significant positive association between both childhood physical and sexual abuse and the risk of chronic pain conditions in adulthood (Lampe et al., 2000; Walker et al., 1988; Walsh et al., 2007). However, only recently has research begun to explore the impact of childhood emotional abuse on health conditions among adults (Eriksen et al., 2016; Hu, Link, McNaughton-Collins, Barry, & McKinlay, 2007). For example, a significant positive association has been found between childhood emotional abuse and chronic pelvic pain among American adults (Hu et al., 2007), and between childhood emotional abuse and overall chronic pain among Indigenous and non-indigenous Norwegian adults (Eriksen et al., 2016). Potential pathways linking childhood emotional abuse and adult chronic pain likely involve psychological factors in addition to physiological impacts from emotional abuse, including negative impacts on brain development, over-activation of the hypothalamus-pituitary-adrenal axis leading to inappropriate release of cortisol, and negative impacts on the immune system (Burke, Finn, McGuire, & Roche, 2017; Carpenter et al., 2009). In order to cope with the impacts from emotional abuse itself including psychological distress, individuals may also engage in injection drug use (Dias, Sales, Hessen, & Kleber, 2015).

To our knowledge, no studies have focused on the association between childhood emotional abuse and chronic pain among PWID. This is concerning, as PWID are known to have higher rates of both chronic pain and childhood emotional abuse compared with non-drug using populations. Further, inadequate pain control has been associated with subsequent substance use following withdrawal management among people with substance use disorders (Larson et al., 2007). In light of these serious concerns, and using data from long-running prospective cohorts of people who use drugs in Vancouver, we sought to evaluate the relationship between childhood emotional abuse and chronic pain among PWID in Vancouver, Canada.

METHODS

Study Procedures

The Vancouver Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS) are ongoing open prospective cohort studies of adults who use drugs, who have been recruited through word of mouth, street outreach, and referrals from community organizations in Vancouver, Canada. The study setting of Vancouver includes the Downtown Eastside (DTES), which is home to a large open drug scene (Miller et al., 2006) with a range of harm reduction programs and treatments for substance use disorders. These studies have been described in detail previously (Strathdee et al., 1998; Wood & Kerr, 2006). Briefly, VIDUS enrolls HIV-negative persons who report injecting an illicit drug at least once in the month preceding enrollment. ACCESS enrolls HIV-positive individuals who report using an illicit drug (other than, or in addition to, cannabis) in the previous month. For both cohorts, other eligibility criteria include being aged 18 years or older, residing in the greater Vancouver region, and providing written informed consent. The study instruments and all other follow-up procedures for each study are harmonized to permit combined analyses. At baseline and semi-annually thereafter, participants complete an interviewer-administered questionnaire eliciting socio-demographic data as well as information pertaining to drug use patterns, risk behaviours, and health care utilization. Nurses collect blood samples for HIV and hepatitis C virus serology, provide basic medical care, and provide referrals to appropriate health care services if required. Participants receive a $40 (CDN) honorarium for each study visit. The University of British Columbia/Providence Health Care Research Ethics Board provided ethical approval for both studies.

Participants were included in the present analysis if they reported ever injecting drugs and had completed at least one study visit between June 1, 2014 (the first follow-up period that included questions about chronic pain via the Brief Pain Inventory (Cleeland & Ryan, 1994)) and November 30, 2016 (the most recent follow-up data available for the present analysis). No other exclusion criteria applied to participants.

Study Variables

The primary outcome variable of interest was reporting chronic pain in the previous six months (yes vs. no). Having chronic pain was defined as responding “Yes” to the question: “Throughout our lives, most of us have had pain from time to time. In the last 6 months, have you had any major or persistent pain (other than minor headaches, sprains, etc.)?” and subsequently responding either “4 to 6 months” or “Longer than 6 months” to the question: “How long have you experienced this pain? (For multiple pain types, check the longest pain duration to date.)” This measure of chronic pain is consistent with that of the International Association for the Study of Pain, which defines chronic pain as “pain that persists beyond normal tissue healing time, which is assumed to be three months” (Merskey, 1986). This measure refers to generalized chronic pain that is not specific to location or syndrome type.

The primary explanatory variable of interest was experiencing moderate to extreme emotional abuse during childhood, as measured during the baseline interview by the Childhood Trauma Questionnaire (CTQ). The CTQ is a commonly used 28-item validated instrument used to retrospectively assess three forms of childhood abuse (sexual, physical, and emotional abuse) and two forms of childhood neglect (physical and emotional neglect) (Bernstein et al., 2003; Scher, Stein, Asmundson, McCreary, & Forde, 2001; Taplin, Saddichha, Li, & Krausz, 2014). The CTQ provides a score for five subscales that correspond to each type of abuse and neglect, based on responses to five items. Using a five-point Likert scale from “never true” (1) to “very often true” (5), participants respond to statements such as “People in my family called me things like ‘stupid,’ ‘lazy,’ or ‘ugly’” (emotional abuse). All questions refer only to events that occurred during childhood, without specifying an age cut-off distinguishing childhood from adulthood. Each subscale produces scores ranging from 5 to 25. We used recommended and pre-determined cut-off scores to translate the emotional abuse subscale score into one of four levels of childhood trauma: none or minimal (5–8), low to moderate (9–12), moderate to severe (13–15), and severe to extreme (>15) (Bernstein, 1998). For this analysis, we chose to collapse these four trauma levels into two: none/low (5-12) and moderate/extreme (>13), as has been done in previous studies (Lake, Wood, et al., 2015). This was done as previous studies have demonstrated a lack of significant findings associated with reporting low levels of childhood abuse within drug using populations (Medrano, Hatch, Zule, & Desmond, 2002). The reliability and validity of the CTQ has been demonstrated previously, and the instrument has been used successfully in several studies of illicit drug-using populations (Bernstein et al., 2003; Lake, Hayashi, et al., 2015; Scher, Stein, Asmundson, McCreary, & Forde, 2001).

We also considered secondary explanatory variables that might confound the relationship between childhood emotional abuse and reporting recent chronic pain, based on previous research (Walsh et al., 2007). These included socio-demographic characteristics, including: age (per year older); biological sex at birth (female vs. male); ancestry (white vs. non-white); homelessness in the previous six months, defined as having no fixed address, sleeping on the street, or staying in a shelter or hostel (yes vs. no); residing in the DTES in the previous six months (yes vs. no); and educational attainment (less than high school diploma vs. high school diploma or higher). Drug-use variables referred to behaviours in the previous six months, and included: ≥ daily heroin use (yes vs. no); ≥ daily prescription opioid non-medical use (yes vs. no); ≥ daily cocaine use (yes vs. no); ≥ daily crack cocaine use (yes vs. no); ≥ daily crystal methamphetamine use (yes vs. no); and heavy alcohol use, defined by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as more than 3 drinks per day or more than 7 drinks per week for females and more than 4 drinks per day or more than 14 drinks per week for males (yes vs. no) (NIAAA). Other exposures included: childhood physical abuse (moderate/extreme vs. none/low); childhood sexual abuse (moderate/extreme vs. none/low); childhood physical neglect (moderate/extreme vs. none/low); childhood emotional neglect (moderate/extreme vs. none/low); ever diagnosed with mental health illness (yes vs. no); engagement in opioid agonist therapy in the previous six months (yes vs. no); and HIV serostatus (positive vs. negative). The other forms of childhood abuse and neglect, including sexual abuse, physical abuse, physical neglect, and emotional neglect were also measured using the Childhood Trauma Questionnaire. As was done with emotional abuse we used the same cut-off scores of none or minimal (5–8), low to moderate (9–12), moderate to severe (13–15), and severe to extreme (>15). The trauma subscores were also translated into two levels: none/low and moderate/extreme.

Statistical Analysis

As a first step, we examined the baseline sample characteristics stratified by chronic pain, using the Pearson’s Chi-squared test (for binary variables) and Wilcoxon Rank Sum test (for continuous variables). Fisher’s exact test was used when one or more of the cells contained expected values less than or equal to five.

Since the analyses of reporting chronic pain included serial measures for each participant, we used generalized estimating equations (GEE) with logit link, which provided standard errors adjusted by multiple observations per person using an exchangeable correlation structure. We first used bivariable GEE analyses to examine the association between each explanatory variable and chronic pain. To examine the relationship between childhood emotional abuse and chronic pain, we fit multivariable GEE models using a conservative confounding model selection approach. We included all variables that were associated with chronic pain in unadjusted analyses at p < 0.10 in a full multivariable model, and used a stepwise approach to fit a series of reduced models. The value of 0.10 was chosen to remain inclusive while balancing the number of potential confounders included in the multivariable model to avoid overloading the model. After comparing the value of the coefficient of childhood emotional abuse in each reduced model, we dropped the secondary variable associated with the smallest relative change. We continued this iterative process until the minimum change exceeded 5 %. We also quantified the severity of multicollinearity using the variance inflation factor (VIF). Variables with a VIF squared ≥3 were considered to be dependent and further examined using phi coefficient (Pearson correlation coefficient estimated for pairs of binary variables) at baseline. All p-values are two sided and tests were considered statistically significant at p <0.05. All statistical analyses were performed using R software version 3.2.4 (R Foundation for Statistical Computing, Vienna, Austria [2016]).

RESULTS

In total, 2223 participants enrolled in the VIDUS or ACCESS studies between December 2005 and June 2017. A total of 699 participants were not eligible due to not completing an interview during the study period, 36 participants were not eligible due to not reporting injection drug use ever, and 29 participants were not eligible due to missing data. Therefore, 1,459 participants were eligible for the present study. Among this sample, 518 (35.5%) were women, 820 (56.2%) self-reported white ancestry, and the median age at baseline was 47.7 years (interquartile range [IQR] = 39.1–54.0). Overall, the 1,459 individuals contributed 5,428 observations to the analysis and the median number of follow-up visits was 4 (IQR: 3–5) per person. The baseline characteristics of all participants stratified by reporting chronic pain are presented in Table 1. As shown, among the 1,459 individuals included in the study, 591 (40.5%) reported moderate to extreme childhood emotional abuse and 760 (52.1%) reported chronic pain in the previous six months at baseline. In addition, the extent of overlap among those who reported childhood emotional abuse with additional maltreatment categories are presented in Table 2. Among the 591 participants who reported childhood emotional abuse, 418 (70.7%) also reported physical abuse, 328 (55.5%) also reported sexual abuse, 297 (50.3%) also reported physical neglect, and 450 (76.1%) also reported emotional neglect.

Table 1:

Baseline sample characteristics, stratified by reporting chronic pain in the past six months among people who inject drugs in Vancouver, Canada (n = 1,459).

Characteristic  Reporting chronic pain *
p - value
Yes
n (%)
760(52.1)
No
n (%)
699(47.9)
Childhood emotional abuse
Moderate/extreme 330 (43.4) 261 (37.3) 0.015
None/low 385 (50.7) 397 (56.8)
Childhood physical abuse
Moderate/extreme 273 (35.9) 206 (29.5) 0.006
None/low 441 (58.0) 454 (64.9)
Childhood sexual abuse
Moderate/extreme 239 (31.4) 190 (27.2) 0.046
None/low 470 (61.8) 472 (67.5)
Childhood physical neglect
Moderate/extreme 226 (29.7) 189 (27.0) 0.181
None/low 479 (63.0) 469 (67.1)
Childhood emotional neglect
Moderate/extreme 356 (46.8) 328 (46.9) 0.819
None/low 343 (45.1) 324 (46.4)
Age
Median, IQR 49 (42-54) 46 (38-53) <0.001
Sex
Female 280 (36.8) 238 (34.0) 0.260
Male 474 (62.4) 456(65.2)
Ancestry
White 433 (57.0) 387 (55.4) 0.476
Other 311 (40.9) 300 (42.9)
Homelessness*
Yes 143 (18.8) 138 (19.7) 0.662
No 615 (80.9) 560 (80.1)
DTES residency*
Yes 451 (59.3) 395 (56.5) 0.273
No 309 (40.7) 304 (43.5)
Educational attainment
Less than high school 373 (49.1) 355 (50.8) 0.400
High school diploma or higher 370 (48.7) 322 (46.1)
Daily heroin use*
Yes 163 (21.4) 150 (21.5) 0.996
No 597 (78.6) 549 (78.5)
Daily prescription opioid use*
Yes 57 (7.5) 22 (3.1) <0.001
No 703 (92.5) 677 (96.9)
Daily cocaine use*
Yes 44 (5.8) 36 (5.2) 0.592
No 716 (94.2) 663 (94.8)
Daily crack cocaine use*
Yes 102 (13.4) 91 (13.0) 0.829
No 658 (86.6) 607 (86.8)
Daily crystal methamphetamine
Yes 98 (12.9) 87 (12.4) 0.797
No 662 (87.1) 612 (87.6)
Heavy alcohol use*
Yes 111 (14.6) 112 (16.0) 0.465
No 646 (85.0) 586 (83.8)
Mental health diagnosis ever
Yes 517 (68.0) 422 (60.4) 0.002
No 241 (31.7) 276 (39.5)
Engaged in OAT*
Yes 431 (56.7) 349 (49.9) 0.009
No 328 (43.2) 350 (50.1)
HIV Serostatus
Positive 338 (44.5) 266 (38.1) 0.013
Negative 422 (55.5) 433 (61.9)

IQR: interquartile range; DTES: Downtown Eastside; OAT: opioid agonist therapy

*

Denotes activities in the previous six months

Refers to any route of consumption (i.e., sniffing, snorting, smoking or injecting)

Table 2.

Extent of overlap with additional maltreatment categories among people who inject drugs who reported childhood emotional abuse in Vancouver, Canada (n = 591).

Child maltreatment category Number of those who reported % of overlap
Childhood Physical Abuse 418 70.7
Childhood Sexual Abuse 328 55.5
Childhood Physical Neglect 297 50.3
Childhood Emotional Neglect 450 76.1

The results of the bivariable and multivariable GEE analyses of reporting chronic pain are presented in Table 3. Childhood physical abuse was removed from the multivariable model due to collinearity with childhood emotional abuse. Physical abuse and emotional abuse resulted in VIF squared >4 and their phi coefficient was 0.68 indicating high collinearity. As shown, in the final multivariable model after adjusting for a range of potential confounders, experiencing childhood emotional abuse remained independently and positively associated with reporting chronic pain (adjusted odds ratio [AOR] = 1.25; 95% confidence interval [CI]: 1.01-1.53).

Table 3.

Bivariable and multivariable GEE analysis of reporting chronic pain among people who inject drugs in Vancouver, Canada (n = 1459).

Unadjusted
Adjusted
Characteristic Odds Ratio (95% CI) p - value Odds Ratio (95% CI) p - value
Childhood emotional abuse
Moderate/extreme 1.38 (1.16-1.63) <0.001 1.25 (1.01-1.53) 0.037
None/low Ref Ref
Childhood physical abuse
Moderate/extreme 1.44 (1.21-1.72) <0.001
None/low Ref
Childhood sexual abuse
Moderate/extreme 1.32 (1.10-1.58) 0.002 1.18 (0.95-1.46) 0.127
None/low Ref Ref
Childhood physical neglect
Moderate/extreme 1.25 (1.04-1.50) 0.017 1.09 (0.89-1.35) 0.388
None/low Ref Ref
Childhood emotional neglect
Moderate/extreme 1.05 (0.89-1.24) 0.567
None/low Ref
Age
(per year older) 1.03 (1.02-1.04) <0.001 1.04 (1.03-1.05) <0.001
Sex
Female 1.09 (0.92-1.29) 0.332
Male Ref
Ancestry
White 1.12 (0.95-1.33) 0.166
Other Ref
Homelessness*
Yes 1.08 (0.92-1.27) 0.333
No Ref
DTES residency*
Yes 1.10 (0.97-1.25) 0.143
No Ref
Educational attainment
Less than high school diploma 0.94 (0.80-1.12) 0.503
High school diploma or higher Ref
Daily heroin use*
Yes 1.09 (0.94-1.26) 0.247
No Ref
Daily prescription opioid use*
Yes 1.49 (1.16-1.91) 0.002
No Ref
Daily cocaine use*
Yes 0.85 (0.66-1.11) 0.235
No Ref
Daily crack cocaine use*
Yes 1.07 (0.89-1.27) 0.473
No Ref
Daily crystal methamphetamine use*
Yes 0.90 (0.75-1.08) 0.269
No Ref
Heavy alcohol use*
Yes 0.94 (0.80-1.09) 0.415
No Ref
Mental health diagnosis ever
Yes 1.49 (1.26-1.77) <0.001 1.50 (1.25-1.80) <0.001
No Ref Ref
Engaged in OAT*
Yes 1.19 (1.03-1.37) 0.020 1.26 (1.08-1.47) 0.003
No Ref Ref
HIV Serostatus
Positive 1.29 (1.09-1.52) 0.003
Negative Ref

GEE: generalized estimating equations; CI: confidence interval; DTES: Downtown Eastside; OAT: opioid agonist therapy

*

Denotes activities in the previous six months.

Refers to any route of consumption (i.e., sniffing, snorting, smoking or injecting).

DISCUSSION

There was a substantial prevalence (40.5%) of self-reported childhood emotional abuse (of moderate to extreme extent) among our sample of PWID in Vancouver, Canada. In addition, a high prevalence of chronic pain (52.1%) was observed at baseline. In a multivariable analysis, childhood emotional abuse remained independently and positively associated with reporting adult chronic pain after adjusting for a range of potential confounders.

Our finding of a significant positive association between childhood emotional abuse and chronic pain is consistent with previous research documented in non-substance using populations (Eriksen et al., 2016; Tietjen et al., 2010). This provides further evidence that childhood exposures might increase the likelihood of chronic pain in adulthood beyond what is already conferred through injection drug use. Given the detrimental impact of childhood emotional abuse on long-term health outcomes, effective early interventions are needed to address this ongoing problem. The information gained through the current study could be used to tailor and target support services for parents and children in safe and supportive non-judgemental ways.

Known risk factors for emotional abuse include children whose parents have mental illness challenges, substance use disorders, are unemployed, and those younger than 22 years of age (Stith et al., 2009). The relationship between childhood emotional abuse and chronic pain persisted even after adjusting for other forms of childhood maltreatments such as sexual abuse, emotional neglect, and physical neglect, suggesting the profound impact of emotional abuse as indicated in previous research (Gilbert et al., 2009). Although we were unable to discern the effect of emotional abuse from that of physical abuse due to the collinearity, other research has shown that the vast majority of physical abuse cases in childhood also demonstrate signs of childhood emotional abuse (Kaplan et al., 1999). Due to this overlap, existing interventions aimed at addressing childhood physical abuse should also consider emphasizing novel responses to address concomitant childhood emotional abuse.

Prior research has suggested some potential physiological and psychological pathways linking childhood emotional abuse and chronic pain during adulthood. Physiologically, chronic stress from emotional abuse in childhood has been shown to impact brain development. For example, exposures to emotional forms of abuse during childhood have been found to over-activate the hypothalamus-pituitary-adrenal axis resulting in a sustained release of cortisol, leading to inappropriate and chronic activation of the inflammatory arm of the immune system (Carpenter et al., 2009; Kuhlman, Chiang, Horn, & Bower, 2017). In turn, the resulting increase of allostatic load, or increased wear and tear on the body, increases the risk of pain conditions (Kuhlman et al., 2017). In addition, psychological development can be impaired by emotional abuse resulting in inappropriate emotional regulation and increased risk of depression and anxiety (Kendall-Tackett, 2002; Neumann, 2017). This can lead to utilizing inappropriate coping strategies for pain, including catastrophizing and activity avoidance, which are known contributors for acute pain becoming chronic (Odes et al., 2017).

Importantly, the physiological and psychological maldevelopments are also shaped by broader social and structural forces. While these were not explored in this study, they are important to acknowledge as they add to the broader discussion of relationships between early life experiences and adult health. Adult survivors of childhood emotional abuse often have poor social networks limiting the ability to depend on others, which is known to be associated with increased stress and isolation, leading to physiological and mental health damages (Kendall-Tackett, 2002). Also, households with a low socioeconomic status and educational attainment have been associated with children experiencing maltreatment, challenges relating to others, and poor emotional control (Sidebotham, Heron, & Team, 2006; Thomson, Guhn, Richardson, Ark, & Shoveller, 2017; Thomson, Guhn, Richardson, & Shoveller, 2017). These can result in low educational attainment for the children themselves, reducing employment opportunities and forcing individuals into low-paying and physically demanding positions, increasing risk of injury and stress (Jones, Nurius, Song, & Fleming, 2018). The physiological, psychological, and social vulnerabilities work together to increase not only the likelihood of pain occurring but also that pain becoming chronic.

Current clinical treatment approaches for chronic pain focus on the use of prescription opioids. While prescription opioids may be effective for a limited set of acute pain scenarios and cancer-related pain, there remains a lack of evidence to support their effectiveness for long-term treatment of chronic pain, except in the case of some cancers (Volkow & McLellan, 2016). Alternatives to prescription opioids include cognitive behavioural therapy, exercise, yoga, acupuncture, and massage therapy which have been shown to decrease chronic pain in patients (Dillie, Fleming, Mundt, & French, 2008; Volkow & McLellan, 2016). In addition, previously identified pathways between childhood emotional abuse and chronic pain represent potential vulnerabilities that may be amenable to treatment. For example, interventions addressing psychosocial impacts, including improving emotion regulation, self-awareness, and social functioning, have demonstrated a promising first-step in ameliorating previous harms and an area for further research (Cameron, Carroll, & Hamilton, 2018). Another approach involves tampering the overactive stress responses, through relaxation techniques and cognitive therapy (Lin, Wan, & Jamison, 2017). Further, utilizing multidisciplinary trauma-informed treatment approaches to chronic pain have demonstrated effectiveness in reducing chronic pain in patients (Scascighini, Toma, Dober-Spielmann, & Sprott, 2008). Addressing the chronic pain among populations of PWID is particularly essential, as pain is known to drive individuals to use riskier consumption methods and drug sources to obtain pain relief, including injecting illicit heroin (Voon et al., 2014). Reducing chronic pain may also be an effective intervention to address the increased risk of overdose and transmission of infectious agents resulting from self-management of pain through illicit opioid injection (Alford et al., 2016).

This study has several limitations. First, the VIDUS and ACCESS cohorts are not random samples and therefore generalizability of the findings may be limited. Second, data used in the study were mostly based on self-report and thus could be subject to reporting bias, including socially desirable responses. Although self-reported behavioural data has been shown to be largely accurate among adult drug-using populations (Darke, 1998), childhood emotional abuse in particular may date back a few decades, and therefore concerns with recall bias and socially desirable responding remain. Lastly, as with any observational research, unmeasured confounders may exist, although we sought to reduce this bias through adjustment of regression models using key predictors of chronic pain. As this was an observational study, we cannot infer causation between childhood emotional abuse and adult chronic pain.

In summary, we observed high rates of experiencing childhood emotional abuse and chronic pain among adult PWID. We also found that childhood emotional abuse remained independently associated with adult chronic pain after adjusting for other forms of childhood maltreatment and relevant socio-demographic and drug using confounders. These findings demonstrate the need to expand on interventions focusing on improving parenting to decrease child maltreatment as well as those aimed at children identified as exposed to emotional abuse to prevent future health impacts. Finally, our findings also emphasize the importance of adopting trauma-informed approaches to pain treatment among this population.

ACKNOWLEDGEMENTS:

The authors thank the study participants for their contribution to the research, as well as current and past researchers and staff. The study was supported by the US National Institutes of Health (NIH) (U01DA038886, U01DA021525). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports Dr. Evan Wood, and the Canadian Institutes of Health Research (CIHR) Canadian Research Initiative on Substance Misuse (SMN–139148). Dr. Kanna Hayashi is supported by a CIHR New Investigator Award (MSH-141971), a Michael Smith Foundation for Health Research (MSFHR) Scholar Award, and the St. Paul’s Foundation. Pauline Voon is supported by doctoral scholarships from the CIHR Vanier Canada Graduate Scholarship and the Pierre Elliott Trudeau Foundation. Dr. M-J Milloy is supported by a CIHR New Investigator Award, a MSFHR Scholar Award, and the US NIH (U01DA021525). His institution has received an unstructured gift from NG Biomed, Ltd., to support him. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

ABBREVIATIONS

DTES:

Downtown Eastside

HIV:

Human immunodeficiency virus

PWID:

People who inject drugs

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

DECLARATIONS OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.

REFERENCES:

  1. Alford DP, German JS, Samet JH, Cheng DM, Lloyd-Travaglini CA, & Saitz R (2016). Primary care patients with drug use report chronic pain and self-medicate with alcohol and other drugs. J Gen Intern Med, 31(5), 486–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrew R, Derry S, Taylor RS, Straube S, & Phillips CJ (2014). The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice, 14(1), 79–94. [DOI] [PubMed] [Google Scholar]
  3. Bernstein DP, Fink L (1998). Childhood Trauma Questionnaire: A Retrospective Self-Report Manual. San Antonio, TX: The Psychological Corporation. [Google Scholar]
  4. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, … Zule W. (2003). Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl, 27(2), 169–190. [DOI] [PubMed] [Google Scholar]
  5. Breivik EL, Collett B, Ventafridda V, Cohen R, & Gallacher D (2006). Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain, 10(4), 287–287. [DOI] [PubMed] [Google Scholar]
  6. Burke NN, Finn DP, McGuire BE, & Roche M (2017). Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanisms. J Neurosci Res, 95(6), 1257–1270. doi: 10.1002/jnr.23802 [DOI] [PubMed] [Google Scholar]
  7. Cameron LD, Carroll P, & Hamilton WK (2018). Evaluation of an intervention promoting emotion regulation skills for adults with persisting distress due to adverse childhood experiences. Child Abuse Negl, 79, 423–433.doi: 10.1016/j.chiabu.2018.03.002 [DOI] [PubMed] [Google Scholar]
  8. Cammack AL, & Hogue CJ (2017). Retrospectively self-reported age of childhood abuse onset in a United States nationally representative sample. Inj Epidemiol, 4(1), 7. doi: 10.1186/s40621-017-0103-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, & Price LH (2009). Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry, 66(1), 69–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chang YP, & Compton P (2013). Management of chronic pain with chronic opioid therapy in patients with substance use disorders. Addict Sci Clin Pract, 8, 21. doi: 10.1186/1940-0640-8-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheung CW, Qiu Q, Choi SW, Moore B, Goucke R, & Irwin M (2014). Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines. Pain Physician, 17(5), 401–414. [PubMed] [Google Scholar]
  12. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, … Deyo RA. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine, 162(4), 276–286. [DOI] [PubMed] [Google Scholar]
  13. Cleeland CS, & Ryan KM (1994). Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore, 23(2), 129–138. [PubMed] [Google Scholar]
  14. Darke S (1998). Self-report among injecting drug users: a review. Drug Alcohol Depend, 51(3), 253–263; discussion 267-258. [DOI] [PubMed] [Google Scholar]
  15. Dias A, Sales L, Hessen DJ, & Kleber RJ (2015). Child maltreatment and psychological symptoms in a Portuguese adult community sample: the harmful effects of emotional abuse. Eur Child Adolesc Psychiatry, 24(7), 767–778. [DOI] [PubMed] [Google Scholar]
  16. Dillie KS, Fleming MF, Mundt MP, & French MT (2008). Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med, 21(2), 108–117. [DOI] [PubMed] [Google Scholar]
  17. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, & Giles WH (2001). Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA, 286(24), 3089–3096. [DOI] [PubMed] [Google Scholar]
  18. Eriksen AMA, Schei B, Hansen KL, Sorlie T, Fleten N, & Javo C (2016). Childhood violence and adult chronic pain among indigenous Sami and non-Sami populations in Norway: a SAMINOR 2 questionnaire study. Int J Circumpolar Health, 75(1), 32798. doi: 10.3402/ijch.v75.32798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fayaz A, Croft P, Langford R, Donaldson L, & Jones G (2016). Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ open, 6(6), e010364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, & Janson S (2009). Burden and consequences of child maltreatment in high-income countries. Lancet, 373(9657), 68–81. doi: 10.1016/s0140-6736(08)61706-7 [DOI] [PubMed] [Google Scholar]
  21. Glaser D (2002). Emotional abuse and neglect (psychological maltreatment): a conceptual framework. Child Abuse Negl, 26(6-7), 697–714. [DOI] [PubMed] [Google Scholar]
  22. Heimer R, Zhan W, & Grau LE (2015). Prevalence and experience of chronic pain in suburban drug injectors. Drug & Alcohol Dependence, 151, 92–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hu JC, Link CL, McNaughton-Collins M, Barry MJ, & McKinlay JB (2007). The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey. J Gen Intern Med, 22(11), 1532–1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, … Pignone MP. (2006). Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res, 6(1), 46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jackson T, Thomas S, Stabile V, Shotwell M, Han X, & McQueen K (2016). A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low-and middle-income countries: trends in heterogeneous data and a proposal for new assessment methods. Anesthesia & Analgesia, 123(3), 739–748. [DOI] [PubMed] [Google Scholar]
  26. Jones TM, Nurius P, Song C, & Fleming CM (2018). Modeling life course pathways from adverse childhood experiences to adult mental health. Child Abuse Negl, 80, 32–40. doi: 10.1016/j.chiabu.2018.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kairys SW, & Johnson CF (2002). The psychological maltreatment of children--technical report. Pediatrics, 109(4), e68. [DOI] [PubMed] [Google Scholar]
  28. Kaplan SJ, Pelcovitz D, & Labruna V (1999). Child and adolescent abuse and neglect research: A review of the past 10 years. Part I: Physical and emotional abuse and neglect. J Am Acad Child Adolesc Psychiatry, 38(10), 1214–1222. [DOI] [PubMed] [Google Scholar]
  29. Kendall-Tackett K (2002). The health effects of childhood abuse: four pathways by which abuse can influence health. Child Abuse Negl, 26(6-7), 715–729. [DOI] [PubMed] [Google Scholar]
  30. Kerr T, Stoltz JA, Marshall BD, Lai C, Strathdee SA, & Wood E (2009). Childhood trauma and injection drug use among high-risk youth. J Adolesc Health, 45(3), 300–302. doi: 10.1016/j.jadohealth.2009.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kuhlman KR, Chiang JJ, Horn S, & Bower JE (2017). Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease. Neurosci Biobehav Rev, 80, 166–184. doi: 10.1016/j.neubiorev.2017.05.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lake S, Hayashi K, Milloy MJ, Wood E, Dong H, Montaner J, & Kerr T (2015). Associations between childhood trauma and non-fatal overdose among people who inject drugs. Addict Behav, 43, 83–88. doi: 10.1016/j.addbeh.2014.12.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lake S, Wood E, Dong H, Dobrer S, Montaner J, & Kerr T (2015). The impact of childhood emotional abuse on violence among people who inject drugs. Drug Alcohol Rev, 34(1), 4–9. doi: 10.1111/dar.12133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lamé IE, Peters ML, Vlaeyen JW, Kleef M. v., & Patijn J (2005). Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. European Journal of Pain, 9(1), 15–24. [DOI] [PubMed] [Google Scholar]
  35. Lampe A, Sölder E, Ennemoser A, Schubert C, Rumpold G, & Söllner W (2000). Chronic pelvic pain and previous sexual abuse. Obstetrics & Gynecology, 96(6), 929–933. [DOI] [PubMed] [Google Scholar]
  36. Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, &Samet JH (2007). Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction, 102(5), 752–760. [DOI] [PubMed] [Google Scholar]
  37. Lin YC, Wan L, & Jamison RN (2017). Using Integrative Medicine in Pain Management: An Evaluation of Current Evidence. Anesth Analg, 125(6), 2081–2093. doi: 10.1213/ane.0000000000002579 [DOI] [PubMed] [Google Scholar]
  38. Medrano MA, Hatch JP, Zule WA, & Desmond DP (2002). Psychological distress in childhood trauma survivors who abuse drugs. Am J Drug Alcohol Abuse, 28(1), 1–13. [DOI] [PubMed] [Google Scholar]
  39. Merskey HE (1986). Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. (1986). Pain Suppl, 3, S1–226. [PubMed] [Google Scholar]
  40. Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, & Wood E (2006). Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse, 41(2), 199–210. doi: 10.1080/10826080500391795 [DOI] [PubMed] [Google Scholar]
  41. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Rethinking Drinking: Alcohol and your health. Available at: https://www.rethinkingdrinking.niaaa.nih.gov/How-much-is-too-much/Is-your-drinking-pattern-risky/Whats-At-Risk-Or-Heavy-Drinking.aspx [Accessed July 17, 2018].
  42. Neumann E (2017). Recollections of emotional abuse and neglect in childhood as risk factors for depressive disorders and the need for psychotherapy in adult life. J Nerv Ment Dis, 205(11), 873–878. doi: 10.1097/nmd.0000000000000748 [DOI] [PubMed] [Google Scholar]
  43. Norman RE, Byambaa M, De R, Butchart A, Scott J, & Vos T (2012). The long-term health consequences of child physical abuse, emotional abuse, and neglect: a systematic review and meta-analysis. PLoS Med, 0(11), e1001349 doi: 10.1371/journal.pmed.1001349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, … Israel Ibd Research N (2017). Simple pain measures reveal psycho-social pathology in patients with Crohn’s disease. World J Gastroenterol, 23(6), 1076–1089. doi: 10.3748/wjg.v23.i6.1076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rees CA (2010). Understanding emotional abuse. Arch Dis Child, 95(1), 59–67. doi: 10.1136/adc.2008.143156 [DOI] [PubMed] [Google Scholar]
  46. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, & Portenoy RK (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA, 259(18), 2370–2378. doi: 10.1001/jama.289.18.2370 [DOI] [PubMed] [Google Scholar]
  47. Rosenblum A, Marsch LA, Joseph H, & Portenoy RK (2008). Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol, 16(5), 405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Scascighini L, Toma V, Dober-Spielmann S, & Sprott H (2008). Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology, 47(5), 670–678. doi: 10.1093/rheumatology/ken021 [DOI] [PubMed] [Google Scholar]
  49. Scher CD, Stein MB, Asmundson GJ, McCreary DR, & Forde DR (2001). The childhood trauma questionnaire in a community sample: psychometric properties and normative data. J Trauma Stress, 14(4), 843–857. doi: 10.1023/a:1013058625719 [DOI] [PubMed] [Google Scholar]
  50. Schilling C, Weidner K, Brahler E, Glaesmer H, Hauser W, & Pohlmann K (2016). Patterns of Childhood Abuse and Neglect in a Representative German Population Sample. PLoS One, 11(7), e0159510. doi: 10.1371/journal.pone.0159510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sidebotham P, Heron J, & Team AS (2006). Child maltreatment in the “children of the nineties”: A cohort study of risk factors. Child Abuse Negl, 30(5), 497–522. [DOI] [PubMed] [Google Scholar]
  52. Stith SM, Liu T, Davies LC, Boykin EL, Alder MC, Harris JM, … Dees J (2009). Risk factors in child maltreatment: A meta-analytic review of the literature. Aggress Violent Behav, 14(1), 13–29. [Google Scholar]
  53. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, … Hogg RS (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280(6), 547–549. [DOI] [PubMed] [Google Scholar]
  54. Taplin C, Saddichha S, Li K, & Krausz MR (2014). Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection. Subst Use Misuse, 49(10), 1311–1316. [DOI] [PubMed] [Google Scholar]
  55. Thomson KC, Guhn M, Richardson CG, Ark TK, & Shoveller J (2017). Profiles of children’s social-emotional health at school entry and associated income, gender and language inequalities: a cross-sectional population-based study in British Columbia, Canada. BMJ open, 7(7), e015353. doi: 10.1136/bmjopen-2016-015353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Thomson KC, Guhn M, Richardson CG, & Shoveller J (2017). Associations between household educational attainment and adolescent positive mental health in Canada. SSM Popul Health, 3, 403–410. doi: 10.1016/j.ssmph.2017.04.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tietjen GE, Brandes JL, Peterlin BL, El off A, Dafer RM, Stein MR, … Khuder SA (2010). Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache, 50(1), 32–41. [DOI] [PubMed] [Google Scholar]
  58. Treede R-D, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, … First MB (2015). A classification of chronic pain for ICD-11. Pain, 156(6), 1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. van Hecke O, Torrance N, & Smith BH (2013). Chronic pain epidemiology and its clinical relevance. Br J Anaesth, 111(1), 13–18. doi: 10.1093/bja/aet123 [DOI] [PubMed] [Google Scholar]
  60. Volkow ND, & McLellan AT (2016). Opioid abuse in chronic pain-misconceptions and mitigation strategies. New England Journal of Medicine, 374(13), 1253–1263. [DOI] [PubMed] [Google Scholar]
  61. Voon P, Callon C, Nguyen P, Dobrer S, Montaner J, Wood E, & Kerr T (2014). Self-management of pain among people who inject drugs in Vancouver. Pain Manag, 4(1), 27–35. doi: 10.2217/pmt.13.62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Walker E, Katon W, Harrop-Griffiths J, Holm L, Russo J, & Hickok LR (1988). Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry, 145(1), 75. [DOI] [PubMed] [Google Scholar]
  63. Walsh CA, Jamieson E, MacMillan H, & Boyle M (2007). Child abuse and chronic pain in a community survey of women. Journal of Interpersonal Violence, 22(12), 1536–1554. [DOI] [PubMed] [Google Scholar]
  64. Wood E, & Kerr T (2006). What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. International Journal of Drug Policy, 17(2), 55–60. doi: 10.1016/j.drugpo.2005.12.007 [DOI] [Google Scholar]

RESOURCES